Medicinal Genomics

What Medicinal Genomics does

Medicinal Genomics Corps is a Woburn, Massachusetts-based molecular diagnostics company founded by Kevin McKernan, formerly a research director on the Human Genome Project at MIT and the first to sequence the cannabis genome. The company develops and commercializes qPCR-based testing assays, DNA extraction kits, instrumentation, and genomic services targeting microbial safety, plant pathogen detection, sex determination, and genotyping for cannabis, hemp, supplement, and natural-product matrices. Core offerings include the PathoSEEK multiplex qPCR assay family (Salmonella, STEC, E. coli, Listeria, Aspergillus, Total Yeast and Mold, Total Aerobic Count), MaGiC Lysis sample-prep kits, the BMS Mic qPCR Cycler and Myra Liquid Handler (sold under a November 2023 partnership with Bio Molecular Systems), StrainSEEK whole-genome sequencing, CannSNP90 genotyping, FemINDICAtor plant sex detection, PsiloSEEK mushroom speciation, and the Grim Reefer free-DNA removal kit. Multiple PathoSEEK assays hold AOAC Performance Tested Methods certifications on cannabis and supplement matrices, and the company manufactures under ISO 13485 quality systems.

Name

Medicinal Genomics

Legal name

Medicinal Genomics Corps

Website

https://medicinalgenomics.com

Company type

Private

Founded year

2011

Operating status

Operating

Headcount range

11–50 employees

Short description

Medicinal Genomics is a Woburn, MA-based molecular diagnostics company that develops AOAC-certified qPCR assays, DNA extraction kits, instruments, and genomic services for microbial and pathogen testing of cannabis, hemp, supplement, and natural-product manufacturers, labs, and cultivators.

Ownership category

akta.pro rank

Product category

Molecular Diagnostics and Cannabis Testing Reagents

NAICS

In-Vitro Diagnostic Substance Manufacturing (325413), Analytical Laboratory Instrument Manufacturing (334516)

SIC

In Vitro & In Vivo Diagnostic Substances (2835), Laboratory Analytical Instruments (3826), Services-Testing Laboratories (8734)

akta.pro primary industry

Molecular & Genetic Testing (PCR/NGS/qPCR) (HLAGADAF)

Keywords

• QPCR detection assays
• Cannabis microbial testing
• Plant sex identification
• Strain verification genomics
• Molecular diagnostics kits

Headquarters

HQ city

Amsterdam

HQ country

Netherlands

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales, Supply Chain

Revenue model

1. qPCR Detection Assays and Kits: Medicinal Genomics generates revenue primarily through sale of qPCR detection assay kits, DNA extraction reagents, and multiplex testing panels. These consumable products are sold in kits that include all necessary reagents for specific microbial targets. Customers include testing labs, manufacturers, and cultivators who purchase recurring consumable supplies.
2. Instruments and Equipment: Sale of Mic qPCR Cycler and Myra Liquid Handler instruments. These represent capital equipment purchases for labs implementing the testing platform.
3. Genomic Services: Fee-for-service genomic sequencing and analysis including StrainSEEK whole genome sequencing, CannSNP90 genotyping, and PathoSEEK ID microbial speciation services.
4. Automation Solutions: Turnkey automation solutions integrating with third-party liquid handling systems from Agilent, Hamilton Robotics, and MGI/BGI for high-throughput laboratory operations.

Pricing tiers

Go-to-market motion2 records

Distribution channels4 records

Marketing channels7 records

Core offering

Medicinal Genomics designs, manufactures, and sells qPCR-based molecular testing kits, reagents, and instruments for the cannabis, hemp, supplement, and natural products industries. Its product line includes PathoSEEK microbial detection assays, MaGiC Lysis Kits, the BMS Mic qPCR Cycler and BMS Myra Liquid Handler, plus genomic services such as StrainSEEK strain identification and CannSNP90 authentication. The company serves regulated cannabis testing laboratories, cultivators, and supplement/food manufacturers in more than 15 countries.

Product overview

Medicinal Genomics offers a comprehensive qPCR-based molecular testing platform for cannabis, hemp, and natural products. The core PathoSEEK qPCR Detection Assays platform is supported by MaGiC Lysis and SenSATIVAx DNA extraction kits, BMS Mic qPCR Cycler and Myra Liquid Handler instrumentation, and genomic services including StrainSEEK sequencing and PathoSEEK ID microbial speciation. Additional offerings include FemINDICAtor plant sex detection, PsiloSEEK mushroom speciation, plant pathogen assays, and the Grim Reefer Free DNA Removal Kit. The company also provides automation solutions integrating with Agilent, Bio-Rad, Hamilton Robotics, and MGI/BGI platforms.

Differentiator

Problem solved

Functional benefit

Brands

• PathoSEEK: qPCR Detection Assays platform for microbial testing
• MaGiC Lysis
• StrainSEEK
• CannSNP90
• FemINDICAtor
• PsiloSEEK
• CannMed
• Grim Reefer
• SenSATIVAx

Products and services

• PathoSEEK qPCR Detection Assays Validated qPCR-based detection assays for microbial and pathogen contamination testing in cannabis and hemp flower and products, used by regulated testing laboratories and cultivators for release testing.
• MaGiC Lysis Kits Sample preparation kits designed to extract DNA from cannabis and hemp matrices for downstream qPCR detection on the PathoSEEK platform, used by testing laboratories.
• BMS Mic qPCR Cycler Compact benchtop qPCR thermal cycler instrument purpose-built for cannabis and supplement testing laboratories running the PathoSEEK qPCR assay workflow.
• BMS Myra Liquid Handler Automated liquid handling instrument that prepares qPCR reaction plates for high-throughput cannabis and supplement testing laboratories.
• StrainSEEK Genomic sequencing service that identifies and authenticates cannabis and hemp strains, providing genetic verification for cultivators, dispensaries, and testing laboratories.
• CannSNP90 SNP-based genotyping panel and service for cannabis genetic verification, used by cultivators and breeders to confirm cultivar identity and genetic relationships.
• FemINDICAtor qPCR assay for early plant sex identification in cannabis and hemp, used by cultivators to separate male plants from female plants early in the growth cycle.
• PsiloSEEK qPCR detection assay for identifying and authenticating psilocybin mushroom species and products, used by mycology testing laboratories and supplier/manufacturers.
• Grim Reefer qPCR detection assay for cannabis-specific pathogens, used to screen flower and products for microbial contamination in regulated testing workflows.

Quantifiable outcome

• Reduce hold and release times from a week to a day
• +7 more outcomes

Named customers22 records

Segments4 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration7 records

Feature10 records

Partnerships

18 partnerships are on record, tiered core.

• Bio Molecular Systems (BMS)coreTechnology or Integration · 8 November 2023Partnership agreement giving Medicinal Genomics rights to market BMS's qPCR Mic instrument and Myra Liquid Handler. This partnership provides an integrated testing platform combining BMS's instrument hardware with MGC's PathoSEEK assays and protocols, creating a turnkey solution for cannabis and hemp microbial testing.
• Analogic SolutionscoreChannel Partner/ Reseller/ DistributorAuthorized distributor for Medicinal Genomics products covering Caribbean region including Trinidad and Tobago, Guyana, French Guyana, and Suriname.
• Analytical Technologies S.A.coreChannel Partner/ Reseller/ DistributorAuthorized distributor covering Central America and South America region including Argentina and surrounding countries.
• Gentech BioSciencescoreChannel Partner/ Reseller/ DistributorAuthorized distributor for Colombia covering that market with local sales and support capabilities.
• Green GeneticscoreChannel Partner/ Reseller/ DistributorAuthorized distributor for Puerto Rico providing local access to Medicinal Genomics testing products.
• SanitascoreChannel Partner/ Reseller/ DistributorAuthorized distributor for Colombia covering that market with local sales and support capabilities.
• TagacacoreChannel Partner/ Reseller/ DistributorAuthorized distributor for Uruguay providing local access to Medicinal Genomics products.
• AlphachromcoreChannel Partner/ Reseller/ DistributorAuthorized distributor covering Croatia, Bosnia and Herzegovina, Kosovo, and Slovenia in Eastern Europe.
• CannabreezecoreChannel Partner/ Reseller/ DistributorAuthorized distributor covering Greece and Malta, providing Mediterranean region coverage.
• DiagnostechcoreChannel Partner/ Reseller/ DistributorAuthorized distributor for South Africa providing African market access.
• Eldan Electronic Instruments Ltd.coreChannel Partner/ Reseller/ DistributorAuthorized distributor covering Israel and Palestine for Medicinal Genomics products.
• Life BiomedicalscoreChannel Partner/ Reseller/ DistributorAuthorized distributor for Northern Macedonia covering that market.
• Paralab SAcoreChannel Partner/ Reseller/ DistributorAuthorized distributor covering Czechia, Germany, Netherlands, and Spain. New distributor partnership.
• SoquimicacoreChannel Partner/ Reseller/ DistributorAuthorized distributor for Portugal providing Iberian Peninsula coverage.
• Genomax TechnologiescoreChannel Partner/ Reseller/ DistributorAuthorized distributor covering Thailand, Singapore, and Malaysia for Southeast Asian market access.
• Agilent TechnologiescoreTechnology or IntegrationTurnkey automation solutions provider for high-throughput laboratory operations using Agilent liquid handling systems integrated with Medicinal Genomics PathoSEEK assays.
• Hamilton RoboticscoreTechnology or IntegrationTurnkey automation solutions provider for laboratory automation integration with Medicinal Genomics testing platform.
• MGI/BGIcoreTechnology or IntegrationTurnkey automation solutions provider for high-throughput sequencing and laboratory automation integration.

Scale indicators4 records

Recent moves6 records

Expansion highlights6 records

Broad incumbents

• Agilent Technologies: Manufacturer of the AriaMx Real-Time PCR System, explicitly validated for PathoSEEK assays, and a turnkey automation partner for MGC's high-throughput solutions. Agilent's broader analytical-instrument portfolio and large installed base position it as both a channel partner and a potential competing reagent supplier.
• Eurofins Scientific: World's largest food and environmental testing services company operating hundreds of laboratories. Competes with MGC on the testing-services side (PathoSEEK ID, StrainSEEK) and is a potential partner for high-throughput cannabis sample speciation work.
• QIAGEN: Global molecular diagnostics and sample-preparation company with qPCR reagent portfolios across food, pharma, and human diagnostics. Comparable reagent/customer base and shared molecular-testing technology stack make QIAGEN a natural competitor as cannabis testing scales.
• Neogen Corporation: Food and animal safety testing company formed via the 3M Food Safety merger, with molecular pathogen detection capabilities. Directly competes for the supplement/nutraceutical testing customers MGC is targeting as an adjacent market.
• Thermo Fisher Scientific: QuantStudio qPCR instruments are validated for PathoSEEK assays per MGC documentation. As the largest life-science tools company, Thermo Fisher could readily launch its own cannabis/hemp-validated kits and reagents, posing a structural threat to MGC's reagent business.
• Bio-Rad Laboratories: Major manufacturer of qPCR instruments (notably the CFX96 Touch) that are explicitly validated for use with Medicinal Genomics' PathoSEEK assays. Bio-Rad is a broad life-science incumbent with the R&D and distribution scale to expand into cannabis-specific qPCR kits, making it the most direct platform competitor.
• Bio-Techne: Life-science reagents and diagnostics company with qPCR and genomic product lines. Comparable technology platform and reagent-sales model, particularly in the molecular research and diagnostics segments MGC serves.
• bioMérieux: Leading food and clinical pathogen-testing company with established molecular (PCR-based) product lines. As MGC expands from cannabis into supplements and natural products, bioMérieux is the dominant incumbent it must displace, with much larger sales coverage and brand recognition.
• Charles River Laboratories: Major contract research and laboratory services company with microbial and molecular testing capabilities serving biopharma and food safety. Comparable end-customer profile and service-revenue model relevant to MGC's genomic services and PathoSEEK ID offerings.

Direct peers

• Hygiena: Specializes in PCR-based food and environmental pathogen detection kits and instruments sold to testing labs and food manufacturers. Closely comparable technology stack and customer type (labs needing validated microbial detection), though focused on food/environmental rather than cannabis/hemp matrices.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat6 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xx.com/medigenomics
• YouTubeyoutube.com/@medicinal.genomics
• Facebookfacebook.com/freecbd
• LinkedInlinkedin.com/company/medicinal-genomics
• Instagraminstagram.com/medicinal.genomics

Compliance7 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds1 record

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Medicinal Genomics